Jane Street Group, LLC Avenue Therapeutics, Inc. Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$1.48 - $2.65 $19,771 - $35,401	-13,359 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.41 - $7.11 $32,195 - $94,982	13,359 New	13,359 $34,000
Q1 2021 May 18, 2021	SELL	$4.7 - $7.17 $62,453 - $95,274	-13,288 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$2.95 - $11.04 $39,199 - $146,699	13,288 New	13,288 $79,000
Q3 2020 Nov 17, 2020	SELL	$9.37 - $12.06 $131,273 - $168,960	-14,010 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$8.29 - $11.47 $116,142 - $160,694	14,010 New	14,010 $151,000

Ticker ATXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,127,720
Market Cap $9.25M
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.